|
Category: information only not used for fragrances or flavors
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Food Chemicals Codex Listed: | No |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | information only not used for fragrances or flavors |
| Recommendation for psychotria viridis leaf usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for psychotria viridis leaf flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components notePotential Uses:
Occurrence (nature, food, other): noteSynonyms:
| | ayahuasca leaf | | | chacruna leaf | | | palicourea viridis leaf | | | psychotria glomerata leaf | | | psychotria microdesmia leaf | | | uragoga glomerata leaf | | | uragoga microdesmia leaf | | | uragoga viridis leaf |
Articles:
| PubMed: | Ayahuasca alters structural parameters of the rat aorta. |
| PubMed: | Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence--qualitative results. |
| PubMed: | Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence. |
| PubMed: | Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. |
| PubMed: | Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine. |
| PubMed: | Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage. |
| PubMed: | The globalization of ayahuasca: harm reduction or benefit maximization? |
| PubMed: | Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage. |
| PubMed: | Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. |
| PubMed: | Various alkaloid profiles in decoctions of Banisteriopsis caapi. |
| PubMed: | Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis. |
| PubMed: | Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography. |
| PubMed: | Plants and the central nervous system. |
| PubMed: | [Neurological syndromes associated with the ingestion of plants and fungi with a toxic component (II). Hallucinogenic fungi and plants, mycotoxins and medicinal herbs]. |
| PubMed: | Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. |
| PubMed: | Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture. |
| PubMed: | Absence of alkaloids in Psychotria carthagenensis Jacq. (Rubiaceae). |
| PubMed: | Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. |
|